Document is current
Any future updates will be listed below
-
Authors
von Musil, Clemens Walter
Riederer, Valentina
Pilsbacher, Leonhard
Paulus, Carina Maria
Rudinger, Severin
Bodlee, Sophia
Gmeiner, Jonas
Fischer, Julius
Steffen, Julius
Peterß, Sven
Kääb, Stefan
Sinner, Moritz
Lackermair, Korbinian
Orban, Martin
Massberg, Steffen
Scherer, Clemens
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 15 February 2025
Accepted: 3 July 2025
First Online: 19 July 2025
Declarations
:
: This study received approval by the ethics committee of the Ludwig-Maximilians-University (LMU) Munich (IRB number: 18–001).
: Clemens Scherer: speaker honoraria from AstraZeneca. Martin Orban: speaker honoraria from Abbott Medical, AstraZeneca, Abiomed, Bayer vital, BIOTRONIK, Bristol-Myers Squibb, CytoSorbents, Daiichi Sankyo Deutschland, Edwards Lifesciences Services, Sedana Medical, support for attending meetings from AstraZeneca, stocks from Abbott Laboratories, Abbvie, AstraZeneca, Bayer, Biontech, Bristol-Meyer- Squibb, Curevac, Draegerwerk, Fresenius Medical Care, Gilead sciences, Inari Medical, Johnson&Johnson, Linde, Merck US, Moderna, NovoNordisk, Nuance Communications, Pfizer, Proctor&Gamble, Roche, SAP, Siemens healthiniers, Zoom. Sven Peterß: speaker honoraria and travel compensation from Edwards Lifesciences Services, AstraZeneca, CytoSorbents, Terumo Aortic and CryoLife (Artivion) Remaining authors: no conflicts of interest to declare.
